How Can a False Claims Act Defense Attorney Reduce Corporate Risk?

A claim is false under the FCA if it contains a material misrepresentation or concealment of fact, or if the claimant knew (or should have known under a reckless-disregard standard) that the claim was false or fraudulent when submitted to the government.

The statute does not require proof that the false statement directly caused the government to pay money; rather, liability attaches when a false statement is material to the government's decision to pay. Courts have interpreted materiality broadly to include omissions of facts that, if disclosed, would have led the government to refuse payment or demand a refund. For corporate defendants, this means that incomplete disclosures, inaccurate certifications in compliance documentation, or failures to report known defects in goods or services can trigger liability. The FCA imposes strict liability in some circuits for any false statement, while others apply a "materiality" filter that requires the false statement to be outcome-determinative. Corporate entities must evaluate both the factual accuracy of submissions and the completeness of disclosures made to government agencies.

Scienter under the FCA requires that the defendant act with knowledge that the claim was false, or act in reckless disregard of the truth or falsity of the claim; the statute does not require proof of specific intent to defraud or knowledge that the false claim would result in payment.

This lower scienter threshold—reckless disregard rather than deliberate fraud—expands corporate liability significantly. A company that submits a claim while aware of a substantial risk that the claim is false, or that fails to investigate obvious red flags, may satisfy the scienter element even without evidence of intentional deception. For example, if a contractor submits invoices for work performed under a government contract without verifying that subcontractors actually completed the work as billed, a court may find reckless disregard. Corporate compliance programs, internal audits, and documented investigation protocols become critical defenses; they demonstrate that the entity did not act with the requisite mental state. Conversely, evidence that a company ignored known inaccuracies, suppressed internal audit findings, or failed to implement reasonable controls may support a finding of scienter.

Corporate exposure under the FCA includes treble damages (three times the government's actual loss), civil penalties ranging from approximately $5,500 to $11,000 per false claim (adjusted annually for inflation), and potential liability for the government's costs and attorney's fees if the entity is found liable.

The qui tam mechanism amplifies corporate risk because private whistleblowers can initiate litigation on behalf of the United States, and if the government declines to intervene, the relator may proceed alone and recover a percentage of any judgment or settlement (typically 15 to 30 percent). Corporate entities in healthcare, defense contracting, grants management, and federal loan programs face heightened scrutiny because these sectors involve large volumes of government payments and regulatory compliance certifications. A single false claim can spawn multiple liability theories if the claim is submitted repeatedly or if related certifications are deemed false. For example, a defense contractor that certifies compliance with cost accounting standards while failing to disclose cost overruns may face liability for each false certification, multiplying damages exposure. Additionally, corporate officers and employees may face personal liability, which can create internal governance tensions and complicate settlement strategy.

Common defenses include the public-disclosure bar (which bars qui tam suits based on information already publicly disclosed unless the relator qualifies as an original source), the statute of limitations (which is generally six years from the date of the false claim or three years from when the government knew or should have known of the false claim, whichever is later), and affirmative defenses such as lack of scienter, immateriality, or regulatory compliance.

The public-disclosure bar is a critical procedural threshold; if the allegations in a qui tam complaint are substantially based on information already in the public domain (media reports, government audits, prior litigation), the court may dismiss the suit unless the relator can establish that he or she was an original source with independent knowledge. Corporate defendants should evaluate whether allegations have been previously disclosed to government agencies, reported in litigation, or covered in regulatory proceedings. Additionally, the FCA permits defendants to file a motion to dismiss under Federal Rule of Civil Procedure 12(b)(6) if the complaint fails to plead with particularity the facts supporting each element of the false claim. In New York federal courts, defendants often challenge the sufficiency of pleading in early motions practice to narrow the scope of discovery and reduce litigation costs. The statute of limitations also offers a temporal defense; if the false claim was submitted more than six years before suit, or if the government knew of the falsity more than three years before suit, the claim may be time-barred. Corporate entities should preserve and review internal records, compliance certifications, and government correspondence to identify potential statute-of-limitations defenses and to establish the timeline of knowledge.

In a qui tam suit, the relator (typically a company employee or contractor with knowledge of false claims) files suit under seal and the government has 60 days to decide whether to intervene; if the government declines, the relator may proceed as the real party in interest.

Corporate defendants must recognize that qui tam relators often have firsthand knowledge of internal practices and may possess damaging documents or testimony. The relator's motivation to recover a percentage of damages can create an aggressive litigation posture and willingness to pursue discovery broadly. When a qui tam suit is filed, the corporate defendant receives notice only after the seal is lifted (typically when the government makes its intervention decision), which means the company may have limited time to prepare a response. Strategic considerations include whether to engage with the relator early to assess the strength of allegations, whether to seek settlement discussions before the government's intervention decision, and how to manage internal investigations without creating attorney-client privilege disputes. A corporate entity should also consider whether the relator's allegations, if proven, would expose other government contracts or grants to similar liability, which may expand the universe of damages and complicate settlement calculus. Additionally, if the company settles a qui tam suit, the settlement often includes a civil investigative demand or government audit, which may uncover additional false claims and extend liability exposure.

If the government intervenes in a qui tam suit, it assumes primary control of the litigation and the relator becomes a secondary party; if the government declines to intervene, the relator proceeds as the sole plaintiff and the government retains the right to intervene later or to appeal if the relator loses.

When the government intervenes, corporate defendants face the full resources of the Department of Justice (or a U.S. Attorney's Office) and must anticipate more aggressive discovery, broader subpoena requests, and potential criminal referral if the investigation reveals evidence of fraud. Government intervention also signals that the allegations meet a threshold of credibility and materiality, which can influence settlement negotiations and jury perception. Conversely, if the government declines to intervene, the relator bears the burden of proof and must satisfy the same pleading standards; however, the relator's case may proceed with lower resource constraints and the government may still monitor the suit or enter as amicus curiae. Corporate defendants should evaluate the government's posture carefully; if the government has already initiated a civil investigative demand or criminal investigation, a parallel qui tam suit may indicate coordinated enforcement. The False Claims Act framework permits the government to settle, compromise, or release FCA claims, which means corporate entities should explore settlement discussions with both the government and the relator if intervention occurs.

A corporate entity facing or anticipating FCA exposure should prioritize internal investigation, preservation of documents, evaluation of compliance certifications, and early assessment of settlement value relative to litigation risk.

First, the company should conduct a privilege-protected internal investigation to identify the scope of potentially false claims, the timeline of knowledge, and the factual basis for any scienter defense. This investigation should include interviews with key personnel, review of compliance certifications, audit reports, and government correspondence, and analysis of whether the company had reasonable procedures to detect and prevent false claims. Second, the entity should preserve all documents related to the allegedly false claims, government contracts or grants, compliance certifications, internal audits, and communications with government agencies; failure to preserve documents can result in adverse inference sanctions that may doom the defense. Third, the company should evaluate whether the false claim was isolated or systemic; if systemic, the company may face liability for multiple claims and should assess whether a remedial compliance program and disclosure to the government (via a voluntary disclosure or settlement) would reduce exposure. Fourth, the company should consider whether allegations implicate other government contracts or grants, which would expand damages exposure and complicate settlement strategy. Finally, the entity should evaluate the relator's credibility and incentives, the strength of the government's evidence (if the government has intervened or conducted an investigation), and the likely range of damages to inform settlement negotiations. A corporate defendant should also consider whether a Forgery Defense Attorney or other specialized counsel is necessary if allegations involve document falsification or identity fraud.

A corporate entity should establish and maintain compliance programs that include written policies on accuracy of government submissions, internal audit procedures, employee training on FCA liability, and mechanisms for reporting suspected false claims without retaliation.

Documentation of compliance efforts serves multiple strategic functions: it demonstrates to the government that the company did not act with scienter (because it implemented reasonable procedures to prevent false claims), it may support a defense motion to dismiss if allegations are implausible given the company's documented controls, and it can reduce settlement exposure by showing good faith. The compliance program should specify that all certifications submitted to the government (cost accounting, regulatory compliance, performance metrics) must be verified by designated personnel and supported by contemporaneous documentation. Employees should receive training on the FCA and the company's obligation to report suspected false claims; the company should establish a confidential reporting mechanism (such as a compliance hotline) and enforce a non-retaliation policy. When an employee reports a suspected false claim, the company should investigate promptly, document findings, and take corrective action (such as issuing a corrected submission to the government or refunding overpayments). If the company discovers that false claims have been submitted, it should consider voluntary disclosure to the government, which may result in a reduced settlement (typically 75 percent of actual damages plus penalties) compared to litigation. Documenting this disclosure process and the company's remedial measures strengthens the defense posture and demonstrates to the government that the company is committed to compliance. Corporate entities should also preserve evidence of the compliance program's implementation, including training records, audit reports, and corrective-action documentation, to support any future defense.